Remed Co Ltd (302550)

Currency in KRW
3,000
+45(+1.52%)
Closed·
Earnings results expected in 3 days
302550 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2,9503,040
52 wk Range
2,3004,595
Key Statistics
Bid/Ask
3,000.00 / 3,005.00
Prev. Close
2,955
Open
3,005
Day's Range
2,950-3,040
52 wk Range
2,300-4,595
Volume
57.97K
Average Volume (3m)
75.29K
1-Year Change
-9.7744%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
302550 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Earnings

Latest Release
May 14, 2026
EPS / Forecast
36.00 / --
Revenue / Forecast
7.18B / --
EPS Revisions
Last 90 days

302550 Income Statement

Compare 302550 to Peers and Sector

Metrics to compare
302550
Peers
Sector
Relationship
P/E Ratio
78.2x−2.0x−0.4x
PEG Ratio
−0.890.030.00
Price/Book
2.3x1.2x2.6x
Price / LTM Sales
3.7x2.3x3.1x
Upside (Analyst Target)
-100.0%47.8%
Fair Value Upside
Unlock37.1%6.2%Unlock

Remed Co.,Ltd. engages in the manufacture and supply of medical devices worldwide. The company offers transcranial magnetic stimulator, a technology for the treatment of disorders, such as stroke, autism, dementia, Parkinson's disease, developmental disorders, and tinnitus. It also offers neuro magnetic stimulation systems for helping blood circulation, treating pain, neurons, regenerating cells, and contraction and relaxation of muscles, as well as core muscle strengthening magnetic stimulation to enable building toned and shaped muscles. In addition, the company provides extracorporeal shock wave therapy; and technology to activate the sensory function of prostate and strengthen the pelvic floor muscle by stimulating them with electromagnetic pulse. The company was formerly known as CR Technology Co., Ltd. and changed its name to Remed Co., Ltd. in 2013. Remed Co., Ltd. was founded in 2003 and is headquartered in Daejeon, South Korea.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
46.32K0.15%138.96M
Other Institutional Investors
0.000.00%0.00
Public Companies & Retail Investors
30.86M99.85%92.58B
Total
30.91M100.00%92.72B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Norges Bank Investment Management0.13%39,445118,335
Government Pension Fund Global0.13%39,445118,335

FAQ

What Is the Remed (302550) Stock Price Today?

The Remed stock price today is 3,000 KRW.

What Stock Exchange Does Remed Trade On?

Remed is listed and trades on the KOSDAQ.

What Is the Stock Symbol for Remed?

The stock symbol for Remed is "302550."

What Is the Remed Market Cap?

As of today, Remed market cap is 92.72B KRW.

What Is Remed's Earnings Per Share (TTM)?

The Remed EPS (TTM) is 30.

When Is the Next Remed Earnings Date?

Remed will release its next earnings report on Aug 18, 2026.

From a Technical Analysis Perspective, Is 302550 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Remed Stock Split?

Remed has split 1 times.

How Many Employees Does Remed Have?

Remed has 87 employees.

What is the current trading status of Remed (302550)?

As of Aug 15, 2026, Remed (302550) is trading at a price of 3,000 KRW, with a previous close of 2,955 KRW. The stock has fluctuated within a day range of 2,950 KRW to 3,040 KRW, while its 52-week range spans from 2,300 KRW to 4,595 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.